COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $158,004 | -83.4% | 23,100 | -80.7% | 0.00% | -100.0% |
| Q4 2022 | $949,362 | -73.3% | 119,869 | -67.6% | 0.00% | -75.0% |
| Q3 2022 | $3,554,000 | +2532.6% | 369,783 | +1890.4% | 0.01% | – |
| Q2 2022 | $135,000 | -45.8% | 18,578 | +19.1% | 0.00% | -100.0% |
| Q4 2021 | $249,000 | -82.6% | 15,600 | -84.1% | 0.00% | -75.0% |
| Q1 2021 | $1,434,000 | -43.9% | 98,160 | -37.7% | 0.00% | -81.0% |
| Q1 2020 | $2,556,000 | -78.3% | 157,591 | -75.9% | 0.02% | -40.0% |
| Q4 2019 | $11,773,000 | +544.4% | 653,872 | +625.0% | 0.04% | +483.3% |
| Q3 2019 | $1,827,000 | -48.3% | 90,193 | -43.6% | 0.01% | -50.0% |
| Q2 2019 | $3,533,000 | +514.4% | 159,859 | +279.3% | 0.01% | +500.0% |
| Q1 2019 | $575,000 | -72.9% | 42,147 | -82.0% | 0.00% | -75.0% |
| Q4 2018 | $2,119,000 | -19.4% | 234,105 | +46.9% | 0.01% | +14.3% |
| Q3 2018 | $2,630,000 | +7.3% | 159,415 | -8.9% | 0.01% | 0.0% |
| Q2 2018 | $2,451,000 | -24.6% | 175,072 | +51.6% | 0.01% | -41.7% |
| Q4 2016 | $3,251,000 | – | 115,480 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |